Vaxart, Inc.'s (NASDAQ:VXRT) 39% Share Price Surge Not Quite Adding Up

Simply Wall StAug 20 06:07 ET

B.Riley Financial Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $2.5

Moomoo NewsAug 16 08:31 ET · Ratings

Vaxart's Promising Vaccine Pipeline: Leading in Mucosal Immunity With Government Support and Competitive Advantages

TipRanksAug 16 07:45 ET

Oppenheimer Starts Vaxart at Outperform, Cites Oral Vaccine Focus

Seeking AlphaAug 15 15:53 ET

Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside

BenzingaAug 15 13:57 ET

Express News | Vaxart Shares Are Trading Higher After Oppenheimer Initiated Coverage on the Stock With an Outperform Rating and Announced a $4 Price Target

BenzingaAug 15 11:36 ET